A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors

Clinical trial NCT06390774 · RECRUITING

Trial details

NCT number: NCT06390774
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced, Recurrent or Metastatic Malignancies

Start date: 2024-05-30
Primary completion: 2026-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.